White label – Pompe disease - ClinicalTrials.eu

Study on the Safety and Effectiveness of Sunvozertinib for Patients with Advanced Non-Small Cell Lung Cancer with EGFR or HER2 Mutations

Not recruiting

1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Sunvozertinib
Study on the Safety and Effectiveness of AUTO1 for Adults with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia Using a Drug Combination

Not recruiting

1 1 1 1
Investigated Drugs:
Study on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod

Not recruiting

3 1 1 1
Investigated Diseases:
- Multiple sclerosis relapse
Investigated Drugs:
- Ofatumumab
+2
Study of AMG 193 and IDE397 for Adults with Advanced MTAP-null Solid Tumors and Non-Small Cell Lung Cancer

Not recruiting

1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Amg 193
- Ide397
Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Not recruiting

3 1 1
Investigated Diseases:
- Dry eye
- Sjogren’s syndrome
Investigated Drugs:
- Ianalumab
+3
Study on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
+5
Study on the Long-term Effects of Dupilumab in Preventing Lung Function Decline in Adults with Uncontrolled Moderate to Severe Asthma

Not recruiting

3 1
Investigated Drugs:
- Dupilumab
+1
Comparison of Nilotinib versus Imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission

Not recruiting

3 1 1 1
Investigated Drugs:
- Imatinib
- Nilotinib
Study on the Effectiveness and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Children with Multiple Sclerosis

Not recruiting

3 1 1
Investigated Drugs:
+7
Study of Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Not recruiting

2 1 1
Investigated Diseases:
- Acute myeloid leukaemia recurrent
Investigated Drugs:
- Ziftomenib

powered by

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes